STAAR Surgical Files Proxy Materials

TL;DR

STAAR Surgical filed proxy docs on 9/22/25, more info coming.

AI Summary

STAAR Surgical Company (STAAR) filed a Definitive Additional Materials proxy statement on September 22, 2025, related to its Schedule 14A filing. This filing includes a press release announcing the company's actions, though specific details of the announcement are not provided in this excerpt.

Why It Matters

This filing indicates that STAAR Surgical is providing additional materials to shareholders, likely related to upcoming corporate actions or decisions requiring shareholder input.

Risk Assessment

Risk Level: low — The filing is a standard proxy statement and does not inherently indicate significant new risks for the company.

Key Players & Entities

• STAAR Surgical Company (company) — Registrant
• STAAR (company) — Abbreviated name for STAAR Surgical Company
• 0000718937 (company) — Central Index Key
• 953797439 (company) — EIN
• DE (company) — State of Incorporation
• 1227 (company) — Fiscal Year End
• 1911 WALKER AVE (company) — Business Address Street 1
• MONROVIA (company) — Business Address City
• CA (company) — Business Address State
• 91016 (company) — Business Address ZIP

FAQ

Key Financial Figures

• $28.00 — eceived after September 19, 2025. The $28.00 per share all-cash consideration in the
• $28 — nt value destruction as compared to the $28 per share merger value. The Company's s
• $18.49 — lue. The Company's stock was trading at $18.49 prior to the announcement of the agreem

Filing Documents

• d927871ddefa14a.htm (DEFA14A) — 29KB
• g927871g0922082505710.jpg (GRAPHIC) — 3KB
• 0001193125-25-210031.txt ( ) — 34KB

Forward-Looking Statements

Forward-Looking Statements The information covered by this communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often contain words such as "anticipate," "believe," "expect," "plan," "estimate," "project," "continue," "will," "should," "may," and similar terms. All statements in this communication that are not performance or achievements to be materially different from what is expressed or implied by the forward-looking statements, including, but not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the Alcon merger agreement or could cause the consummation of the proposed transaction to be delayed or to fail to occur; (2) the failure to obtain approval of the proposed transaction from STAAR's stockholders; (3) the failure to obtain certain required regulatory approvals or the failure to satisfy any of the other closing conditions to the completion of the proposed transaction within the expected timeframes or at all; (4) risks related to disruption of management's attention from STAAR's ongoing business operations due to the proposed transaction; (5) the effect of the announcement of the proposed transaction on the ability of STAAR to retain and hire key personnel and maintain relationships with its customers, suppliers and others with whom it does business, or on its operating results and business generally; (6) the ability of STAAR to meet expectations regarding the timing and completion of the transaction; (7) the outcome of any legal proceedings that may be instituted against STAAR related to the proposed transaction; (8) the possibility that STAAR's stock pr

View Full Filing

View this DEFA14A filing on SEC EDGAR